Clinical Trial Update: Platelet Function in Idiopathic Thrombocytopenic Purpura (ITP) Patients With Eltrombopag [Phase 4]

View source ↗

Summary

Phase 4 update on platelet function in Idiopathic Thrombocytopenic Purpura patients treated with eltrombopag. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Thrombocytopenic Purpura

Drugs mentioned

• Eltrombopag (eltrombopag)

Snippet

Sponsor: Ingrid Pabinger, MD | Conditions: Idiopathic Thrombocytopenic Purpura | Phase 4 | Status: COMPLETED